8-K · ABBV
AbbVie files an 8-K on director or officer changes
AbbVie filed a Form 8-K on Oct 15, 2026 at 4:00 PM ET under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).
Under Item 5.02, the filing says: “Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On October 14, 2026, AbbVie Inc. (“AbbVie”) expanded the size of its Board of Directors (the “Board”) from twelve directors to thirteen directors and appointed Dr. John M. …”
Source
- 8-K filed Oct 15, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
AbbVie company file → · More AbbVie filings
Disclosures
- Editor holdings in ABBV
- The editor holds no position in AbbVie (ABBV). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold ABBV.